Phase 1 Musculoskeletal Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

A Study of Human Allogeneic Bone-marrow Derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Musculoskeletal Injuries and/or Degeneration

Musculoskeletal injury

Cellcolabs Clinical LTD.30 enrolled1 locationNCT06074783

Completed

Phase 1

A Phase 1 study to Assess Safety and Tolerability of KER-065 in Healthy Adult Volunteers

Musculoskeletal Disease

Keros Therapeutics, Inc.38 enrolled2 locationsACTRN12623001233617

Recruiting

Phase 1Phase 2

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

Sexual DysfunctionAutoimmune DiseasesNeurologic Disorders+8 more

Thomas Advanced Medical LLC5,000 enrolled1 locationNCT04684602